The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Romanenko A.V.
Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Amelina I.P.
Pirogov Russian National Research Medical University
Vascular inflammation underlies the development of atherothrombotic stroke
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(8‑2): 22‑29
Views: 3292
Downloaded: 81
To cite this article:
Romanenko AV, Amelina IP, Solovieva EYu. Vascular inflammation underlies the development of atherothrombotic stroke. S.S. Korsakov Journal of Neurology and Psychiatry.
2021;121(8‑2):22‑29. (In Russ.)
https://doi.org/10.17116/jnevro202112108222
Atherothrombotic stroke is the one of the most common subtypes of ischemic cerebral circulatory disorders, the cause of which is atherosclerosis of the major arteries of the brain or their branches. The results of recent studies have shown that the atherosclerotic process is based on an inflammatory process in the vascular wall that leads to the initiation of atherosclerosis, endothelial dysfunction, oxidative stress, and the redistribution of various protein components in the blood-brain barrier. As a result, the progression of the described conditions leads to the manifestation of clinical symptoms and the formation of an acute vascular event. Understanding of the molecular components underlying functional disorders and damages of the cerebral vessels gives the key to modern therapy strategies. It is forming the foundation for the adequate, pathogenetically reasonable drug correction. For such patients, it should be aimed at the normalization of cerebral and central hemodynamics and incorporate the mechanisms of neuroplasticity. The drug 2-ethyl-6-methyl-3-oxypyridine-succinate (mexidol) can be considered as one of the pathogenetically justified agents in complex drug therapy of brain ischemia.
Keywords:
Authors:
Romanenko A.V.
Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Amelina I.P.
Pirogov Russian National Research Medical University
Received:
28.04.2021
Accepted:
28.06.2021
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.